Molecules and mechanisms implicated in the peculiar antigenic activation process of human Vγ9Vδ2T cells

被引:46
|
作者
Harly, Christelle [1 ,2 ]
Peigne, Cassie-Marie [3 ,4 ,5 ]
Scotet, Emmanuel [3 ,4 ,5 ]
机构
[1] NCI, Lab Genome Integr, Ctr Canc Res, Bethesda, MD 20892 USA
[2] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA
[3] Ctr Rech Cancerol Nantes Angers, INSERM, Unite Mixte Rech 892, Nantes, France
[4] Univ Nantes, Nantes, France
[5] CNRS, Unite Mixte Rech 6299, Nantes, France
来源
FRONTIERS IN IMMUNOLOGY | 2015年 / 5卷
关键词
human gamma delta T lymphocytes; functions; antigenic activation; phosphoantigens; butyrophilin; DELTA-T-CELLS; NONPEPTIDIC MYCOBACTERIAL LIGANDS; PRENYL PYROPHOSPHATE ANTIGENS; BURKITTS-LYMPHOMA CELLS; TCR-GAMMA-DELTA; DENDRITIC-CELLS; ISOPRENOID BIOSYNTHESIS; TUMOR-CELLS; PHOSPHORYLATED ANTIGENS; V-GAMMA-2V-DELTA-2; TCR;
D O I
10.3389/fimmu.2014.00657
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In human beings, as well as in most non-human primates, the major peripheral gamma delta T cell subset, which accounts several percent of the whole lymphoid cells pool in adults, carries an heterodimeric TCR composed of V gamma 9 and V delta 2 chains. V gamma 9V delta 2 T cells are specifically and strongly activated by small organic pyrophosphate molecules termed phosphoantigens (phosphoAg). These low molecular weight compounds are metabolites that are produced by either microbes or endogenously, as intermediates of the mammalian mevalonate pathway, and can accumulate intracellularly during cell stress like transformation or infection. Despite the characterization of numerous natural and synthetic phosphoAg, the mechanism(s) underlying the unique and specific antigenic activation process induced by these compounds remains poorly understood. Activation is both TCR-and cell-to-cell contact-dependent, and results of previous studies have also strongly suggested a key contribution of membrane-associated molecules of primate origin expressed on target cells. The recent identification of B7-related butyrophilin (BIN) molecules CD277/BTN3A, and more precisely their BTN3A1 isoforms, as mandatory molecules in the phosphoAginduced recognition of target cells by V gamma 9V delta 2 T cells opens important opportunities for research and applications in this field. Here, we review the unusual and complex antigenic reactivity of human V gamma 9V delta 2 T cells. We highlight the recent advances in our understanding of this process, and propose a model that integrates the type I glycoprotein BTN3A1 and its intracellular B30.2 domain as a physical intermediate implicated in the detection of dysregulated intracellular levels of phosphoAg and the sensing of cell stress by V gamma 9V delta 2T cells. A better understanding of this mechanism will help optimize novel immunotherapeutical approaches that utilize the unique functional potential of this major gamma delta T cell subset.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Low-Density Lipoprotein Uptake Inhibits the Activation and Antitumor Functions of Human Vγ9Vδ2 T Cells
    Rodrigues, Neidy V.
    Correia, Daniel V.
    Mensurado, Sofia
    Nobrega-Pereira, Sandrina
    Debarros, Ana
    Kyle-Cezar, Fernanda
    Tutt, Andrew
    Hayday, Adrian C.
    Norell, Haakan
    Silva-Santos, Bruno
    Dias, Sergio
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (04) : 448 - 457
  • [22] Mechanisms of the Antitumor Activity of Human Vγ9Vδ2 T Cells in Combination With Zoledronic Acid in a Preclinical Model of Neuroblastoma
    Di Carlo, Emma
    Bocca, Paola
    Emionite, Laura
    Cilli, Michele
    Cipollone, Giuseppe
    Morandi, Fabio
    Raffaghello, Lizzia
    Pistoia, Vito
    Prigione, Ignazia
    MOLECULAR THERAPY, 2013, 21 (05) : 1034 - 1043
  • [23] Effector Vγ9Vδ2 T cells dominate the human fetal γδ T-cell repertoire
    Dimova, Tanya
    Brouwer, Margreet
    Gosselin, Francoise
    Tassignon, Joel
    Leo, Oberdan
    Donner, Catherine
    Marchant, Arnaud
    Vermijlen, David
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (06) : E556 - E565
  • [24] Recognition of nonpeptide antigens by human Vγ9Vδ2 T cells requires contact with cells of human origin
    Green, AE
    Lissina, A
    Hutchinson, SL
    Hewitt, RE
    Temple, B
    James, D
    Boulter, JM
    Price, DA
    Sewell, AK
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 136 (03): : 472 - 482
  • [25] 一种经济简单的方法扩增Vγ9Vδ2T细胞
    曹伟
    崔莲仙
    何维
    中华微生物学和免疫学杂志, 2007, (01)
  • [26] Targeting myeloma–osteoclast interaction with Vγ9Vδ2 T cells
    Qu Cui
    Hironobu Shibata
    Asuka Oda
    Hiroe Amou
    Ayako Nakano
    Kenichiro Yata
    Masahiro Hiasa
    Keiichiro Watanabe
    Shingen Nakamura
    Hirokazu Miki
    Takeshi Harada
    Shiro Fujii
    Kumiko Kagawa
    Kyoko Takeuchi
    Shuji Ozaki
    Toshio Matsumoto
    Masahiro Abe
    International Journal of Hematology, 2011, 94 : 63 - 70
  • [27] Vγ9Vδ2 T cell response to colon carcinoma cells
    Corvaisier, M
    Moreau-Aubry, A
    Diez, E
    Bennouna, J
    Mosnier, JF
    Scotet, E
    Bonneville, M
    Jotereau, F
    JOURNAL OF IMMUNOLOGY, 2005, 175 (08): : 5481 - 5488
  • [28] Partial and Ineffective Activation of Vγ9Vδ2 T Cells by Mycobacterium tuberculosis-Infected Dendritic Cells
    Meraviglia, Serena
    Caccamo, Nadia
    Salerno, Alfredo
    Sireci, Guido
    Dieli, Francesco
    JOURNAL OF IMMUNOLOGY, 2010, 185 (03): : 1770 - 1776
  • [30] Human Vγ9Vδ2 T cells:: promising new leads for immunotherapy of infections and tumors
    Bonneville, Marc
    Scotet, Emmanuel
    CURRENT OPINION IN IMMUNOLOGY, 2006, 18 (05) : 539 - 546